iSpecimen Is Trending Overnight — Here's Why ISPC Stock Surged 56% In The After-Hours Session

Benzinga04-10 11:15

iSpecimen Inc. (NASDAQ:ISPC) shares are trending on Thursday night.

ISPC stock jumped 56.19% in after-hours trading to $0.20 on Thursday, after the Massachusetts-based biospecimen marketplace announced a direct supplier-to-customer shipping overhaul, slashing domestic transit times by 70–85%.

According to iSpecimen, the restructured model eliminates centralized hub routing that previously added 7–14 days to delivery. Domestic shipments now arrive in as little as 1–2 days, with fewer handoffs also lowering overall shipping costs.

Rare Specimen Access Expands Into Europe

Internationally, iSpecimen deepened sourcing partnerships across Europe and Eastern Europe, targeting rare and hard-to-source specimens for time-sensitive research needs.

CEO Katie Field cited consistently positive customer feedback since implementation, noting one customer praised the “careful sourcing and handling of the research materials.”

In its fourth-quarter report released last week, iSpecimen posted revenue of $51,760 and reported an earnings per share of -0.74.

Trading Metrics, Technical Analysis

iSpecimen has a market capitalization of $3.73 million, with a 52-week high of $3.18 and a 52-week low of $0.13.

The Relative Strength Index (RSI) of ISPC stands at 33.53.

The small-cap stock of the technology-driven company has dropped 90.84% over the past 12 months.

Price Action: ISPC closed the regular session down 10.34% at $0.13, according to Benzinga Pro. Currently, the stock is positioned at its 52-week low.

Benzinga's Edge Stock Rankings show that ISPC is exhibiting a negative price trend across all time frames.

Photo Courtesy: Rneaw on Shutterstock.com

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment